Streetbeat News

Stock Prices

REPL

Replimune Group's shares are declining following the announcement of primary analysis results from its IGNYTE clinical trial of PR1 in combination with Nivulumab for anti-PBD resistant melanoma at the 2024 ESMO Congress.

Portfolio Pulse from Benzinga Newsdesk

September 16, 2024 | 7:12 pm

ASND

BMRN

Ascendis Pharma's new trial data for TransCon CNP, a treatment for dwarfism, shows promising results, posing a competitive threat to BioMarin's Voxzogo. BioMarin's stock has dropped due to this potential competition, despite its first-mover advantage and ongoing efforts to expand Voxzogo's market presence.

Portfolio Pulse from Vandana Singh

September 16, 2024 | 7:12 pm

AVAV

AeroVironment's shares are declining following a protest filed against a U.S. Army contract awarded to the company. The U.S. Army has issued a stop work order on the contract.

Portfolio Pulse from Benzinga Newsdesk

September 16, 2024 | 7:04 pm

SHIBUSD

Shiba Inu (SHIB) has experienced a 4.88% price drop in the last 24 hours, continuing a week-long decline. Trading volume decreased by 10% while circulating supply increased slightly. SHIB's market cap is ranked #16 at $7.71 billion.

Portfolio Pulse from Benzinga Insights

September 16, 2024 | 7:03 pm

SMCI

Super Micro Computer (SMCI) is expected to release its annual report today following an internal review prompted by a short attack from Hindenburg Research in August.

Portfolio Pulse from Benzinga Newsdesk

September 16, 2024 | 7:03 pm

ADAUSD

Cardano (ADA) has experienced a 3.95% price drop in the last 24 hours, continuing a weekly decline of 4.0%. Trading volume has decreased by 4.0%, while circulating supply increased by 0.41%. Cardano's market cap is ranked #12 at $11.74 billion.

Portfolio Pulse from Benzinga Insights

September 16, 2024 | 7:02 pm

AVAXUSD

Avalanche (AVAX) has seen a 4.37% price drop in the last 24 hours, continuing a week-long decline. Trading volume decreased by 8% while circulating supply increased slightly. AVAX ranks #13 in market cap at $9.48 billion.

Portfolio Pulse from Benzinga Insights

September 16, 2024 | 7:02 pm

BSY

Bentley Systems (NASDAQ:BSY) has been evaluated by 5 analysts over the past three months, with ratings ranging from bullish to indifferent. The average 12-month price target is $59.6, a slight decline from previous estimates. Analysts have maintained or adjusted their ratings, reflecting their views on Bentley's market position and financial performance. Bentley Systems shows strong net margin and ROE but has a higher debt-to-equity ratio than industry averages.

Portfolio Pulse from Benzinga Insights

September 16, 2024 | 7:01 pm

CUZ

Analysts have varied opinions on Cousins Properties (NYSE:CUZ), with recent ratings showing a mix of bullish and indifferent sentiments. The average 12-month price target has increased to $30.17, indicating positive expectations. The company's financials show strong revenue growth and net margin, but challenges in ROE.

Portfolio Pulse from Benzinga Insights

September 16, 2024 | 7:01 pm